AI: DeepSeek (deepseek-chat)

Q: {
  "prompt": "Original Transcript:\n### **Medical Clerking – SBAR Format (Obstetrics & Gynaecology)**  \n\n#### **SITUATION:**  \n- **Patient:** 62F, PMHx of HTN, T2DM, obesity (BMI 38)  \n- **Presenting complaint:** Postmenopausal bleeding (PMB) x 3 months, intermittent, heavy at times. No pain.  \n- **Key clinical issue:** ?Endometrial cancer – urgent assessment required due to high-risk profile (age, obesity, diabetes).  \n\n#### **BACKGROUND:**  \n- **Obstetric/Gynae Hx:** G3P2, LMP 10y ago, no HRT. No previous abnormal smears.  \n- **PMHx:** HTN (amlodipine 5mg OD), T2DM (metformin 1g BD), OSA (CPAP at night).  \n- **SHx:** Non-smoker, occasional ETOH. No FHx of gynae cancers.  \n- **Medications:** As above, no anticoagulants.  \n- **Recent investigations:**  \n  - **TV USS (today):** Endometrial thickness 12mm, heterogeneous appearance, no fibroids.  \n  - **FBC (today):** Hb 112 (mild anaemia), WCC 6.2, Plt 320.  \n\n#### **ASSESSMENT:**  \n- **Clinical exam:**  \n  - **Vitals:** BP 148/86, HR 78, SpO2 98% RA, afebrile.  \n  - **Abdomen:** Soft, non-tender, obese, no masses.  \n  - **PV exam:** No vulval/vaginal lesions, cervix appears normal, scant dark blood in vault. Uterus bulky, no adnexal masses.  \n- **Key findings:**  \n  - **High suspicion for endometrial pathology** (PMB + thickened endometrium).  \n  - **Differentials:**  \n    1. Endometrial cancer (most likely)  \n    2. Endometrial hyperplasia  \n    3. Atrophic endometritis (less likely given USS findings)  \n- **Urgency:** Requires urgent **hysteroscopy + biopsy** for definitive diagnosis.  \n\n#### **RECOMMENDATION:**  \n- **Immediate actions:**  \n  - **Refer to Gynae Oncology MDT** (2WW pathway for PMB).  \n  - **Book urgent hysteroscopy + endometrial biopsy** (OP/inpatient depending on capacity).  \n  - **Pre-op bloods:** FBC, U&E, LFTs, clotting, G&S (in case of anaemia or surgical planning).  \n  - **Consider CT CAP** if biopsy confirms malignancy for staging.  \n- **Monitoring:**  \n  - Repeat Hb pre-op if symptomatic anaemia (consider iron if Hb <100).  \n  - BP/glucose monitoring (optimise HTN/DM pre-op).  \n- **Follow-up:**  \n  - **MDT discussion** post-biopsy for further management (TAH+BSO vs. adjuvant therapy if malignancy confirmed).  \n  - **Counselling re: potential diagnosis & surgical options.**  \n\n**Documented by:** [Your Name]  \n**Role:** FY2 / SHO in Obstetrics & Gynaecology  \n**Date/Time:** [DD/MM/YYYY HH:MM]  \n\n*(For educational purposes only – fictional case.)*  \n\n---  \n**Notes:**  \n- Uses UK-appropriate terminology (e.g., \"2WW pathway\", \"OP\" for outpatient).  \n- Includes key gynae-oncology red flags (PMB, thickened endometrium).  \n- Follows realistic workflow (urgent biopsy, MDT referral).  \n- Abbreviations: PMHx (past medical history), TV USS (transvaginal ultrasound), FBC (full blood count), MDT (multidisciplinary team), TAH+BSO (total abdominal hysterectomy + bilateral salpingo-oophorectomy).\n\nApply these changes:\nACCEPT: Replace \"Missing: pre-procedure patient information and counseling\" with \"Provide written information prior to hysteroscopy appointment including procedure details, benefits/risks, pre-op analgesia advice, and contact details\" (Reason: According to the guideline: 'Written information should be provided to the woman prior to their appointment, including details about the procedure, benefits and risks, advice regarding pre-operative analgesia, and contact details for the hysteroscopy unit.' This is particularly important for this high-risk patient with multiple comorbidities to ensure informed consent and proper preparation.)\nACCEPT: Replace \"Book urgent hysteroscopy + endometrial biopsy\" with \"Book urgent outpatient hysteroscopy using vaginoscopic approach with mechanical tissue removal system if needed\" (Reason: The guideline states: 'Vaginoscopy should be the standard technique for outpatient hysteroscopy unless a vaginal speculum is required' and 'Mechanical hysteroscopic tissue removal systems should be preferred over miniature bipolar electrodes.' This modification ensures optimal technique for this diagnostic procedure in a postmenopausal patient with suspected endometrial pathology.)\nACCEPT: Replace \"Gap: no discussion of pain management plan\" with \"Recommend NSAID premedication 1 hour prior to procedure and use of warmed saline distension medium\" (Reason: Guideline states: 'A statistically significant reduction in pain was demonstrated with NSAIDs' and 'Warming saline to body temperature can be considered for outpatient hysteroscopy.' Given this patient's anxiety about the procedure and the need for adequate tissue sampling, proper pain management is essential.)\nACCEPT: Replace \"Consider CT CAP if biopsy confirms malignancy for staging\" with \"If malignancy confirmed, staging should be determined by MDT including consideration of CT CAP\" (Reason: While the original text is clinically appropriate, the guideline emphasizes multidisciplinary care: 'MDT discussion post-biopsy for further management.' This modification reinforces the MDT approach for this high-risk patient with multiple comorbidities.)\nACCEPT: Replace \"Missing: documentation of consent process\" with \"Document informed consent discussion including procedure risks, pain potential, and alternative options\" (Reason: Guideline states: 'Women should be given verbal and/or written informed consent prior to hysteroscopy, and should be informed of the potential pain and distress during the procedure.' Given this patient's complex history, thorough consent documentation is particularly important.)\nACCEPT: Replace \"Missing: post-procedure care plan\" with \"Plan for post-procedure recovery area and provide contact information for complications\" (Reason: Guideline recommends: 'Care after hysteroscopy should include discussing clinical findings, providing contact information, and offering a dedicated recovery area.' This is especially relevant for this patient given her comorbidities and potential for procedure-related complications.)\n\nReturn the updated transcript with these changes applied.",
  "system_prompt": "You are a medical AI assistant that applies user decisions to clinical transcripts based on guideline suggestions.\n\nYou will receive:\n1. An original transcript\n2. A list of suggestions with user decisions (accept, reject, or modify)\n3. For modifications, the user's custom text\n\nYour task is to apply only the ACCEPTED and MODIFIED suggestions to create an updated transcript. For each change:\n- ACCEPTED suggestions: Apply the suggested text exactly as provided\n- MODIFIED suggestions: Apply the user's modified text instead of the original suggestion\n- REJECTED suggestions: Leave the original text unchanged\n\nReturn the updated transcript as clean, properly formatted medical text. Maintain the original structure and formatting as much as possible while incorporating the accepted changes.\n\nImportant guidelines:\n- Only apply changes that the user has accepted or modified\n- Preserve the medical accuracy and professional tone\n- Maintain logical flow and readability\n- Do not add any explanatory text or comments\n- Return only the updated transcript",
  "session_id": "advice_1751375333163_ezrg3ekq7",
  "original_transcript_length": 2870,
  "changes_applied": 6,
  "decisions_summary": {
    "accepted": 6,
    "modified": 0,
    "rejected": 0
  }
}

A: ### **Medical Clerking – SBAR Format (Obstetrics & Gynaecology)**  

#### **SITUATION:**  
- **Patient:** 62F, PMHx of HTN, T2DM, obesity (BMI 38)  
- **Presenting complaint:** Postmenopausal bleeding (PMB) x 3 months, intermittent, heavy at times. No pain.  
- **Key clinical issue:** ?Endometrial cancer – urgent assessment required due to high-risk profile (age, obesity, diabetes).  

#### **BACKGROUND:**  
- **Obstetric/Gynae Hx:** G3P2, LMP 10y ago, no HRT. No previous abnormal smears.  
- **PMHx:** HTN (amlodipine 5mg OD), T2DM (metformin 1g BD), OSA (CPAP at night).  
- **SHx:** Non-smoker, occasional ETOH. No FHx of gynae cancers.  
- **Medications:** As above, no anticoagulants.  
- **Recent investigations:**  
  - **TV USS (today):** Endometrial thickness 12mm, heterogeneous appearance, no fibroids.  
  - **FBC (today):** Hb 112 (mild anaemia), WCC 6.2, Plt 320.  

#### **ASSESSMENT:**  
- **Clinical exam:**  
  - **Vitals:** BP 148/86, HR 78, SpO2 98% RA, afebrile.  
  - **Abdomen:** Soft, non-tender, obese, no masses.  
  - **PV exam:** No vulval/vaginal lesions, cervix appears normal, scant dark blood in vault. Uterus bulky, no adnexal masses.  
- **Key findings:**  
  - **High suspicion for endometrial pathology** (PMB + thickened endometrium).  
  - **Differentials:**  
    1. Endometrial cancer (most likely)  
    2. Endometrial hyperplasia  
    3. Atrophic endometritis (less likely given USS findings)  
- **Urgency:** Requires urgent **hysteroscopy + biopsy** for definitive diagnosis.  

#### **RECOMMENDMENT:**  
- **Immediate actions:**  
  - **Refer to Gynae Oncology MDT** (2WW pathway for PMB).  
  - **Book urgent outpatient hysteroscopy using vaginoscopic approach with mechanical tissue removal system if needed**  
  - **Pre-op bloods:** FBC, U&E, LFTs, clotting, G&S (in case of anaemia or surgical planning).  
  - **If malignancy confirmed, staging should be determined by MDT including consideration of CT CAP**  
- **Monitoring:**  
  - Repeat Hb pre-op if symptomatic anaemia (consider iron if Hb <100).  
  - BP/glucose monitoring (optimise HTN/DM pre-op).  
- **Follow-up:**  
  - **MDT discussion** post-biopsy for further management (TAH+BSO vs. adjuvant therapy if malignancy confirmed).  
  - **Counselling re: potential diagnosis & surgical options.**  
- **Patient information and preparation:**  
  - **Provide written information prior to hysteroscopy appointment including procedure details, benefits/risks, pre-op analgesia advice, and contact details**  
  - **Recommend NSAID premedication 1 hour prior to procedure and use of warmed saline distension medium**  
  - **Document informed consent discussion including procedure risks, pain potential, and alternative options**  
  - **Plan for post-procedure recovery area and provide contact information for complications**  

**Documented by:** [Your Name]  
**Role:** FY2 / SHO in Obstetrics & Gynaecology  
**Date/Time:** [DD/MM/YYYY HH:MM]  

*(For educational purposes only – fictional case.)*  

---  
**Notes:**  
- Uses UK-appropriate terminology (e.g., "2WW pathway", "OP" for outpatient).  
- Includes key gynae-oncology red flags (PMB, thickened endometrium).  
- Follows realistic workflow (urgent biopsy, MDT referral).  
- Abbreviations: PMHx (past medical history), TV USS (transvaginal ultrasound), FBC (full blood count), MDT (multidisciplinary team), TAH+BSO (total abdominal hysterectomy + bilateral salpingo-oophorectomy).

--- Token Usage Report ---
Prompt tokens: 1584
Completion tokens: 938
Total tokens: 2522
Estimated cost: $0.001261